Researchers at the University of Pennsylvania’s Perelman School of Medicine have introduced a groundbreaking method for producing human artificial chromosomes (HACs), offering immense potential for gene therapy and biotechnology.

Published in Science, their study presents an innovative approach to efficiently create single-copy HACs, overcoming longstanding obstacles in the field.

Led by Dr. Ben Black, the team redesigned HAC design and delivery, utilizing yeast cells to assemble a large DNA construct and then fusing them with human cells.

This method yielded high-efficiency formation of HACs, which replicated and segregated properly during cell division, Study Finds reported.

Importantly, the HACs maintained their integrity and circular topology, without unwanted rearrangements.

The implications are vast, promising safer and more effective gene therapy platforms compared to current methods.

Additionally, HACs could revolutionize agricultural biotechnology.

Although further refinement is needed, this study represents a significant advancement in genome engineering, opening avenues for synthetic biology and genetic manipulation.

The development of stable, single-copy HACs marks a crucial milestone, offering a powerful tool for both medical and research purposes, shaping the future of bioengineering.

Written by B.C. Begley